A single view of all the companies in the same space to infer if the stock is undervalued, overvalued or priced right. This would be one way to analyze a longer terms investment in a particular sector.
| Company | Market Cap | Income | Sales | P/E | P/B | Cash/Share | Dividend | Dividend Yield | Price To Cash Ratio | Debt to Equity Ratio | ROE | ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FSD Pharma Inc. | 49,700,000 | -42,700,000 | 0 | 0.00 | 0.57 | 0.86 | - | - | 1.12 | 0.01 | -58.50% | -51.10% |
| Alimera Sciences, Inc. | 40,810,000 | -4,400,000 | 59,000,000 | 0.00 | 0.00 | 2.25 | - | - | 2.47 | 0.00 | 20.80% | -7.70% |
| Amphastar Pharmaceuticals, Inc. | 1,880,000,000 | 62,100,000 | 437,800,000 | 29.65 | 3.96 | 2.68 | - | - | 13.78 | 0.17 | 14.60% | 9.40% |
| Amneal Pharmaceuticals, Inc. | 1,220,000,000 | 10,600,000 | 2,089,999,999 | 56.09 | 1.61 | 0.79 | - | - | 4.92 | 7.80 | 3.10% | 0.30% |
| Amryt Pharma plc | 620,810,000 | -87,500,000 | 210,200,000 | 0.00 | 1.53 | 1.76 | - | - | 5.04 | 0.66 | -73.60% | -14.30% |
| ANI Pharmaceuticals, Inc. | 559,180,000 | -42,800,000 | 216,100,000 | 0.00 | 1.35 | 5.72 | - | - | 5.58 | 0.86 | -18.60% | -7.80% |
| Assertio Holdings, Inc. | 126,500,000 | -1,300,000 | 111,000,000 | 0.00 | 1.01 | 0.67 | - | - | 3.44 | 0.72 | -1.30% | -0.40% |
| Avadel Pharmaceuticals plc | 253,440,000 | -77,300,000 | 0 | 0.00 | 3.17 | 2.61 | - | - | 1.61 | 1.82 | -71.50% | -28.50% |
| Bausch Health Companies Inc. | 8,010,000,000 | -948,000,000 | 8,430,000,000 | 0.00 | 0.00 | 1.56 | - | - | 13.76 | 0.00 | 317.60% | -3.20% |
| Clever Leaves Holdings Inc. | 47,610,000 | -45,700,000 | 15,400,000 | 0.00 | 0.57 | 1.23 | - | - | 1.28 | 0.34 | -56.50% | -32.30% |
| Collegium Pharmaceutical, Inc. | 605,340,000 | 71,500,000 | 276,900,000 | 10.15 | 2.94 | 5.38 | - | - | 3.25 | 1.23 | 32.60% | 10.20% |
| Cumberland Pharmaceuticals Inc. | 39,300,000 | -5,500,000 | 36,000,000 | 0.00 | 0.88 | 1.75 | - | - | 1.46 | 0.00 | -7.60% | -4.00% |
| Catalent, Inc. | 17,120,000,000 | 563,000,000 | 4,480,000,000 | 27.68 | 3.52 | 4.82 | - | - | 18.71 | 0.94 | 14.00% | 5.90% |
| Emergent BioSolutions Inc. | 2,120,000,000 | 230,900,000 | 1,790,000,000 | 8.92 | 1.26 | 10.39 | - | - | 3.68 | 0.52 | 14.90% | 7.90% |
| Eagle Pharmaceuticals, Inc. | 629,080,000 | -8,600,000 | 171,500,000 | 0.00 | 3.49 | 7.41 | - | - | 6.44 | 0.15 | -4.60% | -3.30% |
| Elanco Animal Health Incorporated | 12,670,000,000 | -472,000,000 | 4,760,000,000 | 0.00 | 1.66 | 1.30 | - | - | 19.86 | 0.84 | -6.00% | -2.80% |
| Endo International plc | 583,300,000 | -569,100,000 | 2,990,000,000 | 0.00 | 0.00 | 5.48 | - | - | 0.39 | 0.00 | 77.90% | -6.70% |
| Evolus, Inc. | 628,630,000 | -46,800,000 | 99,700,000 | 0.00 | 7.74 | 2.65 | - | - | 4.30 | 0.87 | -60.70% | -21.50% |
| Evotec SE | 4,590,000,000 | 0 | 571,470,000 | 15.60 | 4.38 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Flora Growth Corp. | 109,500,000 | -11,600,000 | 1,300,000 | 0.00 | 2.68 | 0.28 | - | - | 5.82 | 0.01 | - | - |
| Harrow Health, Inc. | 185,240,000 | -18,500,000 | 72,500,000 | 0.00 | 15.69 | 1.80 | - | - | 3.65 | 6.35 | -93.20% | -20.30% |
| Ironwood Pharmaceuticals, Inc. | 1,920,000,000 | 528,400,000 | 413,800,000 | 3.77 | 3.28 | 3.94 | - | - | 3.09 | 0.75 | 116.90% | 55.40% |
| Kamada Ltd. | 242,740,000 | 0 | 103,720,000 | 59.56 | 1.26 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Lannett Company, Inc. | 27,230,000 | -288,500,000 | 406,400,000 | 0.00 | 0.00 | 2.32 | - | - | 0.28 | 0.00 | - | -40.70% |
| Neoleukin Therapeutics, Inc. | 61,520,000 | -60,700,000 | 0 | 0.00 | 0.52 | 3.10 | - | - | 0.43 | 0.00 | -37.70% | -33.40% |
| OrganiGram Holdings Inc. | 602,170,000 | -35,300,000 | 107,400,000 | 0.00 | 0.86 | 0.36 | - | - | 3.99 | 0.02 | -7.10% | -6.20% |
| OptiNose, Inc. | 191,320,000 | -82,300,000 | 74,700,000 | 0.00 | 0.00 | 1.29 | - | - | 1.73 | 0.00 | 259.20% | -55.30% |
| Organogenesis Holdings Inc. | 985,300,000 | 94,900,000 | 468,100,000 | 9.72 | 3.68 | 0.80 | - | - | 8.65 | 0.30 | 49.50% | 25.50% |
| Phibro Animal Health Corporation | 792,640,000 | 53,300,000 | 879,400,000 | 14.33 | 3.19 | 2.27 | 0.48 | 2.55% | 8.30 | 1.67 | 23.00% | 6.40% |
| Pacira BioSciences, Inc. | 3,460,000,000 | 42,000,000 | 541,500,000 | 83.20 | 4.66 | 14.50 | - | - | 5.27 | 1.44 | 6.00% | 2.80% |
| PLx Pharma Inc. | 90,280,000 | -48,600,000 | 8,199,999 | 0.00 | 2.72 | 2.70 | - | - | 1.30 | 0.00 | -128.60% | -56.90% |
| PainReform Ltd. | 13,360,000 | -7,200,000 | 0 | 0.00 | 0.70 | 1.56 | - | - | 0.81 | 0.00 | -37.70% | -36.00% |
| Perrigo Company plc | 4,820,000,000 | -130,900,000 | 4,139,999,999 | 0.00 | 0.88 | 13.17 | 0.96 | 2.82% | 2.58 | 0.68 | -1.30% | -0.60% |
| ProPhase Labs, Inc. | 115,430,000 | 6,300,000 | 79,000,000 | 87.53 | 1.88 | 1.06 | - | - | 6.67 | 0.17 | 12.10% | 7.80% |
| Petros Pharmaceuticals, Inc. | 28,770,000 | -9,000,000 | 7,800,000 | 0.00 | 0.39 | 1.05 | - | - | 1.21 | 0.00 | -38.30% | -14.80% |
| Qilian International Holding Group Limited | 64,940,000 | 3,200,000 | 57,100,000 | 18.53 | 1.15 | 0.00 | - | - | 0.00 | 0.14 | 8.00% | 5.40% |
| RedHill Biopharma Ltd. | 106,790,000 | -97,700,000 | 85,800,000 | 0.00 | 10.67 | 0.68 | - | - | 2.81 | 9.87 | -379.40% | -49.40% |
| Radius Health, Inc. | 356,900,000 | -70,200,000 | 230,000,000 | 0.00 | 0.00 | 2.25 | - | - | 3.20 | 0.00 | 29.90% | -36.70% |
| Dr. Reddy's Laboratories Limited | 9,260,000,000 | 255,100,000 | 2,670,000,000 | 34.80 | 3.67 | 1.86 | 0.34 | 0.64% | 28.70 | 0.16 | 11.00% | 7.20% |
| 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Relmada Therapeutics, Inc. | 798,780,000 | -125,800,000 | 0 | 0.00 | 2.34 | 6.77 | - | - | 3.77 | 0.00 | -107.30% | -95.10% |
| SCYNEXIS, Inc. | 93,310,000 | -32,900,000 | 13,200,000 | 0.00 | 1.58 | 0.00 | - | - | 0.00 | 0.98 | -95.90% | -29.20% |
| Sonoma Pharmaceuticals, Inc. | 9,410,000 | -5,600,000 | 12,500,000 | 0.00 | 0.77 | 2.54 | - | - | 1.11 | 0.05 | -71.20% | -34.00% |
| Supernus Pharmaceuticals, Inc. | 1,570,000,000 | 53,400,000 | 579,800,000 | 29.89 | 1.91 | 6.33 | - | - | 4.63 | 0.46 | 6.70% | 3.40% |
| Takeda Pharmaceutical Company Limited | 46,900,000,000 | 3,420,000,000 | 27,000,000,000 | 13.44 | 1.10 | 1.82 | 0.80 | 5.49% | 8.01 | 0.82 | 8.30% | 3.50% |
| Taro Pharmaceutical Industries Ltd. | 1,500,000,000 | 1,100,000 | 566,400,000 | 956.59 | 0.87 | 20.52 | - | - | 1.91 | 0.00 | 0.10% | 0.00% |
| Tricida, Inc. | 712,660,000 | -176,600,000 | 0 | 0.00 | 0.00 | 2.34 | - | - | 5.07 | 0.00 | -716.20% | -92.50% |
| Teva Pharmaceutical Industries Limited | 10,880,000,000 | 417,000,000 | 15,880,000,000 | 24.35 | 0.98 | 1.82 | - | - | 5.03 | 2.24 | 4.10% | 0.90% |
| Theratechnologies Inc. | 244,460,000 | 0 | 70,190,000 | 0.00 | 9.08 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Veru Inc. | 1,180,000,000 | -16,200,000 | 60,800,000 | 0.00 | 7.62 | 1.38 | - | - | 10.20 | 0.09 | -10.60% | -9.10% |
| Viatris Inc. | 13,250,000,000 | -1,269,100,000 | 17,890,000,000 | 0.00 | 0.61 | 0.62 | 0.44 | 4.23% | 16.77 | 1.13 | -6.00% | -2.20% |
| Zoetis Inc. | 87,690,000,000 | 2,040,000,000 | 7,780,000,000 | 42.20 | 18.78 | 7.16 | 1.30 | 0.72% | 25.18 | 1.45 | 46.10% | 14.70% |
| Zynerba Pharmaceuticals, Inc. | 69,220,000 | -37,300,000 | 0 | 0.00 | 0.86 | 1.48 | - | - | 1.02 | 0.00 | -44.80% | -39.50% |